Summit Therapeutics Inc.

Biotechnology • Healthcare • Miami, FL, United States • SMMT (NGM)

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst - Yahoo Finance UK

Yahoo Finance UK • Jan 2

Don't Buy Summit Therapeutics Until This Big Thing Happen - The Motley Fool

The Motley Fool • Dec 3

Summit's High-Profile Drug Flops And Shares Crash - Investor's Business Daily

Investor's Business Daily • Sep 8

Farther Finance Advisors LLC Makes New $1.14 Million Investment in Summit Therapeutics PLC $SMMT - MarketBeat

MarketBeat • Dec 29

Summit Therapeutics Raises $500 Million in Private Placement - Business Wire

Business Wire • Oct 22

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Summit Therapeutics Inc. had layoffs?

No layoff events have been recorded for Summit Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Summit Therapeutics Inc. have?

Summit Therapeutics Inc. has approximately 159 employees.

What industry is Summit Therapeutics Inc. in?

Summit Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Summit Therapeutics Inc. a publicly traded company?

Yes, Summit Therapeutics Inc. is publicly traded under the ticker symbol SMMT on the NGM. The company has a market capitalization of approximately $13.49 billion.

Where is Summit Therapeutics Inc. headquartered?

Summit Therapeutics Inc. is headquartered in Miami, FL, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.